The health ministry of Panama has said it would allow emergency use of the Pfizer Inc (NYSE:PFE)-BioNTech (Nasdaq:BNTX) COVID-19 vaccine for children aged 12 years and older, Reuters news agency reported on Tuesday.
However, no details were given on when it would start.
The health ministry stated that authorisation of the vaccine for children from 12 to 16 was based on data showing it was effective for that age group as well as for adults.
The Pfizer-BioNTech vaccine is already authorised for those older than 16 in Panama.
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses